Cryotherapy chamber

Cryotherapy chamber (Vacuactivus)

Cryotherapy chamber is an individual, tube-shaped device to provide cryotherapy for the human body.[1] This is a type of low-temperature treatment used to reduce inflammation and painful effects.[2][3]

History

In the late 1970s the cryotherapy chamber was developed by Japanese scientist Toshima Yamaguchi.[4][5]

In the 1980s and 1990s it was introduced to Europe and USA.[6][7][8]

As of 2022, the main producers according to MarketWatch research are:

  • CRYONiQ[9]
  • Zimmer MedizinSysteme
  • MECOTEC
  • CRYO Science[9]
  • Vacuactivus[10]

Main uses

Cryotherapy may reduce pain, help with mental disorders, support exercise recovery performance and improve joint function. Cryotherapy chambers are a part of sports rehabilitation and wellness.[11][12]

Among main uses are:

Cryotherapy Chamber Media

References

  1. Bouzigon, Romain. Whole- and partial-body cryostimulation/cryotherapy: Current technologies and practical applications (in en). Journal of Thermal Biology 61 (2016-10-01). p. 67–81. doi:10.1016/j.jtherbio.2016.08.009.
  2. Lombardi, Giovanni. Whole-Body Cryotherapy in Athletes: From Therapy to Stimulation. An Updated Review of the Literature. Frontiers in Physiology 8 (2017-05-02). p. 258. doi:10.3389/fphys.2017.00258.
  3. 3.0 3.1 CryoStar LIQUID NITROGEN-BASED CRYOTHERAPY CHAMBERS | VACUACTIVUS cryotherapy chambers and weight loss machines (in en-US) (2020-12-04). Retrieved 2021-01-21.
  4. Elite Athletes Are Utilizing Cryotherapy For Recovery (in en). patients.scnm.edu. Retrieved 2021-02-23.
  5. Why are people freezing their bodies? (in en). theweek.com (2017-04-18). Retrieved 2021-02-23.
  6. Romuk E, Skrzep-Poloczek B, Wiśniowska B, Owczarek AJ, Choręza P, Sieroń A, Birkner E, Stygar D Biomed Res Int, 2019:2065346, 15 May 2019 Cited by: 1 article | PubMed | PMCID: PMC6541937
  7. The effect of cryotherapy on total antioxidative capacity in patients with active seropositive rheumatoid arthritis. Hirvonen H, Kautiainen H, Moilanen E, Mikkelsson M, Leirisalo-Repo M Rheumatol Int, 37(9):1481–1487, 11 Jul 2017 Cited by: 6 articles | PubMed
  8. Costello, Joseph T.; Baker, Philip Ra; Minett, Geoffrey M.; Bieuzen, Francois; Stewart, Ian B.; Bleakley, Chris (18 September 2015). "Whole-body cryotherapy (extreme cold air exposure) for preventing and treating muscle soreness after exercise in adults"(PDF). The Cochrane Database of Systematic Reviews. 9 (9): CD010789. doi:10.1002/14651858.CD010789.pub2. PMID 26383887.
  9. 9.0 9.1 Local Cryotherapy Machines Market Size From 2022 To 2028 And Key Findings and Segments by End Use Industry (in EN-US). MarketWatch. Retrieved 2022-10-13.[dead link]
  10. About cryotherapy chamber manufacturer (in en-US). VACUACTIVUS cryotherapy chambers and weight loss machines (2020-04-06). Retrieved 2022-10-13.
  11. Zalewski, Pawel. Whole-body cryostimulation increases parasympathetic outflow and decreases core body temperature. Journal of Thermal Biology 45 (October 2014). p. 75–80. doi:10.1016/j.jtherbio.2014.08.001.
  12. Hausswirth, Christophe. Parasympathetic Activity and Blood Catecholamine Responses Following a Single Partial-Body Cryostimulation and a Whole-Body Cryostimulation. PLOS ONE 8 (8) (2013-08-22). p. e72658. doi:10.1371/journal.pone.0072658.
  13. Miller, Elżbieta. Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients. The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry 12 (3) (April 2011). p. 223–227. doi:10.3109/15622975.2010.518626.
  14. Klimenko, Taras. Whole-body cryotherapy in atopic dermatitis. Archives of Dermatology 144 (6) (June 2008). p. 806–808. doi:10.1001/archderm.144.6.806.
  15. Lubkowska, Anna. The effect of prolonged whole-body cryostimulation treatment with different amounts of sessions on chosen pro- and anti-inflammatory cytokines levels in healthy men. Scandinavian Journal of Clinical and Laboratory Investigation 71 (5) (September 2011). p. 419–425. doi:10.3109/00365513.2011.580859.